GSK PLC (GLAXF)
22.54
+0.29
(+1.30%)
USD |
OTCM |
May 17, 16:00
GSK Total Assets (Quarterly): 73.87B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 73.87B |
December 31, 2023 | 75.17B |
September 30, 2023 | 74.26B |
June 30, 2023 | 75.00B |
March 31, 2023 | 72.57B |
December 31, 2022 | 72.79B |
September 30, 2022 | 67.35B |
June 30, 2022 | 108.00B |
March 31, 2022 | 117.82B |
December 31, 2021 | 106.76B |
September 30, 2021 | 105.66B |
June 30, 2021 | 106.58B |
March 31, 2021 | 107.32B |
December 31, 2020 | 109.61B |
September 30, 2020 | 104.10B |
June 30, 2020 | 104.18B |
March 31, 2020 | 104.38B |
December 31, 2019 | 104.49B |
September 30, 2019 | 102.32B |
June 30, 2019 | 80.64B |
March 31, 2019 | 81.34B |
December 31, 2018 | 73.68B |
September 30, 2018 | 76.36B |
June 30, 2018 | 75.35B |
March 31, 2018 | 78.71B |
Date | Value |
---|---|
December 31, 2017 | 76.19B |
September 30, 2017 | 78.94B |
June 30, 2017 | 75.76B |
March 31, 2017 | 73.91B |
December 31, 2016 | 72.58B |
September 30, 2016 | 76.21B |
June 30, 2016 | 77.58B |
March 31, 2016 | 78.29B |
December 31, 2015 | 79.18B |
September 30, 2015 | 80.50B |
June 30, 2015 | 85.10B |
March 31, 2015 | 85.88B |
December 31, 2014 | 63.27B |
September 30, 2014 | 65.45B |
June 30, 2014 | 66.17B |
March 31, 2014 | 66.09B |
December 31, 2013 | 69.40B |
September 30, 2013 | 66.46B |
June 30, 2013 | 64.16B |
March 31, 2013 | 65.18B |
December 31, 2012 | 67.03B |
September 30, 2012 | 65.65B |
June 30, 2012 | 65.88B |
March 31, 2012 | 65.10B |
December 31, 2011 | 63.30B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
67.35B
Minimum
Sep 2022
117.82B
Maximum
Mar 2022
93.64B
Average
104.14B
Median
Total Assets (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | 258.01M |
Biodexa Pharmaceuticals Plc | 13.43M |
Verona Pharma PLC | 289.91M |
NuCana PLC | 35.43M |
Autolus Therapeutics PLC | 375.38M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 57.17B |
Shareholders Equity (Quarterly) | 17.47B |
Debt to Equity Ratio | 1.284 |
Current Ratio | 0.8669 |
Net Debt Paydown Yield | 0.40% |